Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
Haematologica. 2023 Aug 1;108(8):2130-2145. doi: 10.3324/haematol.2022.282049.
Haematologica. 2023.
PMID: 36794499
Free PMC article.
Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG; Risperidone Long-Acting Trial Investigators (R-LAI).
Rossi A, et al.
Hum Psychopharmacol. 2009 Oct;24(7):574-83. doi: 10.1002/hup.1067.
Hum Psychopharmacol. 2009.
PMID: 19790173
Clinical Trial.
Item in Clipboard
Cite
Cite